not exactly NRs' agenda goes something like this ..

New Post Public Reply Private Reply Replies (1) Message Board
4kids Biobum99 #56316
395
not exactly

NRs' agenda goes something like this ..

lull investors and mgmt into a false sense of security
(2012 - 2014) with cycles of money being worked .. this
provides liquidity and entices retail traders .. it also let's
mgmt think they can uplist due to price point *stability* ..

uplisting (when upside down) is the last *reality* that NR (non retail)
.. (who has worked those numerous cycles of money for years) .. wants

exit 2014 .. enter 2015

*agenda* then is crystal clear .. agenda becomes relentless PPS compression
NRs' stall was around 70c~ while name ticker cusip was *worked* thru in 2017/2018

and here we are in 2019 ..

with noticeable pattern change outs re: what NR *reports*

retail has zero control over anything but their respective DD and whether
they buy .. sell or hold their IPIX shares
and clearly some retail have far more business experience than others
while others seem to have far more of a science or medical bent than others

that makes for an interesting read on various SMBs

what was so telling about this SMB .. was for years as NR essentially made
the vehicle of choice for OTC stock manipulation's IPIX SMB .. effectively useless
(my rule of thumb was always a page of 50 posts and % ratios re: negative/positive/neutral)
was when *infestation* would enter *here* to attempt to either control *flow*
or to make this site useless

the timing again is interesting .. perhaps just to me .. March 2019's kickoff
because of the very real and factual *change out* (and alignment imo) with
what NR *reported*

lastly it was equally clear for those willing to take the time to observe .. a week ago Friday

that NR *ran* a mini test .. it was stopped out @ 11:04AM

https://investorshangout.com/post/view?id=5428931

i have no doubts based on 10 years of observation of OTC targets (and to be clear 99.99% of OTC targets do not outlast NR .. let alone survive .. those that do do so with about 1B to 5B I/O) .. that NR absolutely learned *something* that spooked them back in mid to late February 2019

i have no doubts the *run* done last week was a set up by NR .. done for multiple reasons ..

one reason is to condition LT retail investors to sell on the next take up .. (it's conditioning)

i refer to these round trips (PPS starts and essentially ends at the same price point) as NRs' round robining

what is *interesting* about this round done last week is the *volume* injected

which brings me back to the utter lies posted non stop last Fall to EO 2018

Innovation Pharma has an enviable I/O (the I/O is not the Float)
the Float is what is freely traded ..
last year (August) IPIX's I/O was noted (updated by TA on that 4 profit site)

@ 163,103,927 08/30/2018

and from a screen shot from 1.29.19

@ 176,445,648 12/31/2018

so for the 4 months of 2018 (Sep - Dec) when NR injected bogus volume to brutalize investors .. force mgmt into toxic financing and compress IPIX sub 10c
(52 week low reset to 7c on 12.31.18) .. if every share added to the I/O headed
straight to the Float .. that is 13,341,721

however NR injected 54,830,246 shares during that same time frame

13341721 / 54830246 = 24.33%

that is why i've noted the *gamble* undertaken was an epic fail in actually parting
LT investors from their IPIX shares

and even more interesting for those self regulating entities' reporting ..

FTDs *actually* reported began morphing up IPIX's food chain .. making the cherry picked *posts* .. beyond revealing .. but then an educated retail and an
aware OTC mgmt is an upside down NRs' worst NITEmare .. pun intended

4kids
Quote:

Is there manipulation? Well of course there is. Whether or not it’s the brokers solely is another story. It seems larger investors like brokers, MMs, hedge funds merely play a game with the Reg Sho to mask what they are really trying to do. Are they trying to clear a massive short interest or are they leap frogging retail investors to make sure they get the abundance of newly released shares? I’ve been reading some key investors and it looks like to me that non retail are doing what they can to gobble up shares and that’s their main objective. We all seem to be in the same side it’s just the tactics of it all.


















Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navigating the Nitty-Gritty of Cabin Rental Management

Updated Category News Views 10

The Real Elbow Grease Behind Cabin Management Ever imagined what it’d take to keep a vacation rental cabin running like a tight ship? Well, Nathan Fitts breaks it down real clear-like. The guy's seen it all in Blue Ridge, Georgia, which isn't just about scenic views—there's serious business brewing behind that cabin charm. More Than Just Fluffing Pillows Turns out,...

Continue Reading
D2L Ventures into Vietnam with Van Lang Alliance

Updated Category News Views 16

Unlocking New Frontiers in Vietnam's Education Well, looks like D2L is rolling into Vietnam with the kind of gusto you'd expect from a company that fancies itself a trailblazer in learning tech. This ain't just another humdrum expansion story; it's a five-year handshake with Van Lang Education Group that's got the tech firm dropping its anchor in a fresh and promising...

Continue Reading
Navigating AI Laws: A New Era for Privacy & Security

Updated Category News Views 16

Crucial Insights from the Convergence Conference Rich with intrigue, the privacy and AI governance game just upped its stakes. If there ever was a time to listen closely, it's now, people. With over 150 laws sprouting up faster than weeds, businesses are getting squeezed to keep their artificial ducks in a row. Last month over in New York, some big names in law and...

Continue Reading
First Student Reduces Collisions by 63% with HALO Tech

Updated Category News Views 13

Making Every School Bus Ride Safer Here's some good news in the world of transportation, especially if you're keen on keeping kids safe on the daily school bus run. First Student's HALO™ Connected Transportation Platform claims it made a significant dent in reducing accidents—specifically, a 63% cut in forward collision risk. It's a big promise when you're talking...

Continue Reading
Alaska LNG Project Boosted by Strategic Positioning

Updated Category News Views 10

Alaska LNG: Right Place, Right Time Someone bring out the confetti, because Paul Sullivan, Co-Chairman of Gastech, is celebrating Alaska LNG like it's 1999. And for good reason. If Alaska ever played its cards right, now's the moment according to the industry veteran. After Gastech 2026 wrapped its events in Bangkok last month, Sullivan laid out why the stars are aligning...

Continue Reading
DOCS Faces Investor Legal Battle for Alleged Misconduct

Updated Category News Views 11

The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...

Continue Reading
INSPIRE 2026: Luxury Hotel Trends and Investments

Updated Category News Views 5

Luxury Hotels: Where's the Money Headed? All eyes on Orlando this December 15–16, where the International Luxury Hotel Association (ILHA) is calling the shots. INSPIRE 2026 is the marquee event of the year for luxury hospitality, and it ain't just about starry chandeliers and velvet drapes. We're talking real capital shifts, margins pinching tighter, and a future...

Continue Reading
eGlint's Rapid Tech Revolutionizes Proteomics with Win

Updated Category News Views 6

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Continue Reading
OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 8

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading
Senté’s Heparan Sulfate Pairing: Peer-Reviewed Success

Updated Category News Views 8

Senté's Science-Driven Approach in Skincare Alright, cutting through the skincare noise, Senté Labs has pulled off something impressive—not just another jar of promises but actual, peer-reviewed science backing their Defense C Serum. Published in the Journal of Cosmetic Dermatology, this study isn't just talk about ingredients; it's a show of real results. This isn't...

Continue Reading

Top 5 Most Recently Viewed Articles

Ontex's Q3 Results Show Strong Progress Despite Market Challenges

Updated Category News Views 143

Ontex's Financial Performance for Q3 Ontex has released its latest financial results, revealing a noteworthy overall performance in the third quarter. Despite facing some challenges in consumer demand, the company reported a revenue of €445 million, marking a 3.8% year-on-year decrease when compared to comparable periods. However, when assessed against the previous...

Continue Reading
Youth Financial Independence: The Case for 16-Year-Old ISAs

Updated Category News Views 145

Empowering Youth to Manage Their Finances The conversation around financial independence for the younger generation is gaining traction. A recent campaign is advocating that the Government lowers the age for opening Individual Savings Accounts (ISAs) to 16 years old. This proposal aligns with various rights already held by young people, such as leaving school, working...

Continue Reading
Gantry Achieves Milestone with $20 Billion Loan Servicing Growth

Updated Category News Views 104

Gantry Sees Significant Increase in Q3 Loan Production Gantry, known as the largest independent commercial mortgage banking firm in the U.S., has reported impressive growth in new commercial mortgage production for the third quarter. The quarter saw a notable increase of nearly 10% over the totals from both the previous two quarters. This positive trend is bolstered by...

Continue Reading
Icahn Enterprises L.P. to Host Q3 2025 Earnings Call Discussion

Updated Category News Views 144

Upcoming Earnings Conference Call for Icahn Enterprises L.P. Icahn Enterprises L.P. (NASDAQ: IEP) has exciting news to share regarding its upcoming Q3 2025 earnings conference call. This important event will take place on a webcast, scheduled for Wednesday, November 5, 2025, at 10:00 a.m. Eastern Time. Investors and interested parties are encouraged to tune in to hear the...

Continue Reading
Iovance Biotherapeutics Announces Conference Presentations in 2025

Updated Category News Views 697

Iovance Biotherapeutics Announces Upcoming Conference Appearances Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a pioneering biotechnology firm dedicated to advancing treatments through innovative polyclonal tumor infiltrating lymphocyte (TIL) therapies, has revealed that its senior executive team will be showcasing their expertise at several prestigious conferences in...

Continue Reading